Report an adverse event
GSK routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies and the collection of reports and cases of adverse events for marketed products.
This information contributes to the continuing safety surveillance of our products.
If you become aware of a patient who has experienced any adverse event, lack of efficacy, pregnancy, maladministration, overdose or unexpected benefits with one of our products, please contact GlaxoSmithKline by completing the fields below and press submit.
Alternatively you can report the adverse event directly to GSK Cyprus Pharmacovigilance department tel: 0035722397000 and/or to the Pharmacovigilance Committee of the Pharmaceutical Services PO Box 1475 Nicosia (Fax: 22608639) by completing the Yellow Card which is available from the Public Pharmacies or electronically via www.kitrinikarta.gov.cy.
Please note that any personal information shared with GSK will only be used to respond to your adverse event report or enquiry.
GSK does not recommend, endorse or accept liability for sites controlled by third-parties.
*Denotes required field